Ana B. Bueno - Concepedia

Author

Ana B. Bueno

Also Known As

A. B. BUENO, Ana B Bueno, Ana B. Bueno, Ana Belen Bueno, Ana Belén Bueno, Ana Bueno, Bueno, A., Bueno, Ana B., Richard Bax

Publications

925

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (Spain)Universidad Autónoma de Madrid ConfometRx (United States)Colorado State University

About

Ana B. Bueno is an author at Eli Lilly (United States) specializing in organic chemistry, chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	405
2	Biochemistry	6	6	314
3	Engineering	4	4	82
4	Natural Sciences	3	3	126
5	Health Sciences	1	1	105

Ana B. Bueno

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Structural determinants of dual incretin receptor agonism by tirzepatide Bingfa Sun, Francis S. Willard, Dan Feng, Proceedings of the National Academy of Sciences GlycobiologyPharmacotherapyInsulin SignalingGastrointestinal Peptide HormoneMolecular Pharmacology	2022	105
Structural insights into probe-dependent positive allosterism of the GLP-1 receptor Ana B. Bueno, Bingfa Sun, Francis S. Willard, Nature Chemical Biology Molecular PharmacologySignal TransductionMolecular PhysiologyStructural InsightsG Protein-coupled Receptor	2020	91
Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands Denise Wootten, Emilia E. Savage, Francis S. Willard, Molecular Pharmacology	2013	87
Dipeptides as Effective Prodrugs of the Unnatural Amino Acid (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740), a Selective Group II Metabotropic Glutamate Receptor Agonist Ana B. Bueno, Iván Collado, Alfonso de Dios, Journal of Medicinal Chemistry Unnatural Amino AcidPharmacotherapyEffective ProdrugsDrug ResistanceN Dipeptide Derivative	2005	65
Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Journal of Biological Chemistry	2016	59
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1<i>H</i>-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia Michaël Génin, Ana B. Bueno, Javier Agejas Francisco, Journal of Medicinal Chemistry Pharmaceutical ScienceSelective Fxr AgonistFarnesoid X ReceptorPharmacotherapyPotent Fxr	2015	57
Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery Daniel A. Briere, Ana B. Bueno, Ellen J. Gunn, Diabetes	2017	50
Practical synthesis of aromatic ethers by SNAr of fluorobenzenes with alkoxides Ramón Rodríguez, Javier Agejas, Ana B. Bueno Tetrahedron Letters Chemical EngineeringPractical SynthesisEngineeringAlkene MetathesisAromatic Ethers	2006	37
(2<i>S</i>,1‘<i>S</i>,2‘<i>R</i>,3‘<i>R</i>)-2-(2‘-Carboxy-3‘-hydroxymethylcyclopropyl) Glycine Is a Highly Potent Group 2 and 3 Metabotropic Glutamate Receptor Agonist with Oral Activity Iván Collado, Concepción Pedregal, Ana B. Bueno, Journal of Medicinal Chemistry PsychopharmacologyPharmacotherapyMolecular PharmacologyMedicinal ChemistryBiological Activity	2003	36
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR Jason Lamar, Jingdan Hu, Ana B. Bueno, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesPeptide LibraryMechanism Of Action	2003	33

Page 1